Literature DB >> 6511864

Rapid method for the determination of either piroxicam or tenoxicam in plasma using high-performance liquid chromatography.

J S Dixon, J R Lowe, D B Galloway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6511864     DOI： 10.1016/0378-4347(84)80116-4

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics of tenoxicam after oral administration in healthy human subjects of various single doses.

Authors:  R J Francis; J G Allen; D Looi; J S Dixon; H A Bird; V Wright
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jan-Mar       Impact factor: 2.441

2.  Intraocular and plasma kinetics of tenoxicam in rabbits.

Authors:  M Del Puppo; M G Kienle; R Ratiglia; D Galimberti; G Acerbi; L Boerci; L Marabini; E Chiesara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-02       Impact factor: 3.117

Review 3.  Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  J P Gonzalez; P A Todd
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

4.  Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism.

Authors:  Chang-Keun Cho; Pureum Kang; Hye-Jung Park; Eunvin Ko; Chou Yen Mu; Yun Jeong Lee; Chang-Ik Choi; Hyung Sik Kim; Choon-Gon Jang; Jung-Woo Bae; Seok-Yong Lee
Journal:  Arch Pharm Res       Date:  2022-05-31       Impact factor: 4.946

Review 5.  Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.

Authors:  K T Olkkola; A V Brunetto; M J Mattila
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

6.  Effects of tenoxicam on renal function and the disposition of inulin and p-aminohippurate in healthy volunteers and patients with chronic renal failure.

Authors:  S Freestone; J A McAuslane; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

7.  The effects of food and of antacid on the single oral dose pharmacokinetics of tenoxicam.

Authors:  R J Francis; J S Dixon; J R Lowe; P A Harris
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Oct-Dec       Impact factor: 2.441

Review 8.  Clinical pharmacokinetics of tenoxicam.

Authors:  O G Nilsen
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

9.  Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicam.

Authors:  C Benveniste; R Striberni; P Dayer
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.